Form D · Pharmaceuticals

White Sands Pharma LLC

Little Rock, AR · CIK 0001662539

Offering snapshot reported Mar 1, 2018 · SEC filing

Reported sold
$4.3M
Offering amount: $15M
Investors reported
37
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Jan 16, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.15M$4.3MJan 28, 2016: $950,000.00Jan 28, 2016Apr 25, 2017: $3,401,380.00Apr 25, 2017Mar 1, 2018: $4,300,000.00Mar 1, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,401,380 → $4,300,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 1, 2018Amendment$4,300,000$898,620vs Apr 25, 201737SEC filing
Apr 25, 2017Amendment$3,401,380$2,451,380vs Jan 28, 201637SEC filing
Jan 28, 2016Initial$950,000No comparison7SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-256218

Source: Form D, filed Mar 1, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Fix Executive
Brett Matthews Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
401 South Cedar Street
Little Rock, AR, 72205